Amid Woodford debacle, Immunocore cuts valuation as it secures $74M from General Atlantic — report
Immunocore appears to be the latest domino to fall around Neil Woodford’s debacle as it solicits new backing at a drastically lower valuation.
Once a …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.